Top ▲

microtubule affinity regulating kinase 4

Click here for help

Target not currently curated in GtoImmuPdb

Target id: 2100

Nomenclature: microtubule affinity regulating kinase 4

Abbreviated Name: MARK4

Family: MARK subfamily

Contents:

Gene and Protein Information Click here for help
Species TM AA Chromosomal Location Gene Symbol Gene Name Reference
Human - 752 19q13.32 MARK4 microtubule affinity regulating kinase 4
Mouse - 752 7 A3 Mark4 MAP/microtubule affinity regulating kinase 4
Rat - 752 1q21 Mark4 microtubule affinity regulating kinase 4
Previous and Unofficial Names Click here for help
MAP/microtubule affinity-regulating kinase like 1 | MARKL1 | MAP/microtubule affinity-regulating kinase 4
Database Links Click here for help
Alphafold Q96L34 (Hs), Q8CIP4 (Mm)
BRENDA 2.7.11.1
ChEMBL Target CHEMBL5754 (Hs), CHEMBL4523387 (Mm)
Ensembl Gene ENSG00000007047 (Hs), ENSMUSG00000030397 (Mm), ENSRNOG00000017069 (Rn)
Entrez Gene 57787 (Hs), 232944 (Mm), 680407 (Rn)
Human Protein Atlas ENSG00000007047 (Hs)
KEGG Enzyme 2.7.11.1
KEGG Gene hsa:57787 (Hs), mmu:232944 (Mm), rno:680407 (Rn)
OMIM 606495 (Hs)
Pharos Q96L34 (Hs)
RefSeq Nucleotide NM_031417 (Hs), NM_172279 (Mm), NM_001191071 (Rn)
RefSeq Protein NP_113605 (Hs), NP_758483 (Mm), NP_001178000 (Rn)
UniProtKB Q96L34 (Hs), Q8CIP4 (Mm)
Wikipedia MARK4 (Hs)
Enzyme Reaction Click here for help
EC Number: 2.7.11.1

Download all structure-activity data for this target as a CSV file go icon to follow link

Inhibitors
Key to terms and symbols View all chemical structures Click column headers to sort
Ligand Sp. Action Value Parameter Reference
PCC0208017 Small molecule or natural product Click here for species-specific activity table Hs Inhibition 8.7 pIC50 4
⤷ pIC50 8.7 (IC50 2.01x10-9 M) [4]
PCC0105003 Small molecule or natural product Click here for species-specific activity table Hs Inhibition 8.6 pIC50 5
⤷ pIC50 8.6 (IC50 2.67x10-9 M) [5]
compound 14 [PMID: 34333981] Small molecule or natural product Click here for species-specific activity table Hs Inhibition 6.1 pIC50 3
⤷ pIC50 6.1 (IC50 8.08x10-7 M) [3]
Inhibitor Comments
IC50 values for PCC0105003 were generated using the Eurofins KinaseProfiler™ service.
DiscoveRx KINOMEscan® screen Click here for help
A screen of 72 inhibitors against 456 human kinases. Quantitative data were derived using DiscoveRx KINOMEscan® platform.
http://www.discoverx.com/services/drug-discovery-development-services/kinase-profiling/kinomescan
Reference: 2,6
Key to terms and symbols Click column headers to sort
Target used in screen: MARK4
Ligand Sp. Type Action Value Parameter
staurosporine Small molecule or natural product Ligand has a PDB structure Hs Inhibitor Inhibition 8.3 pKd
NVP-TAE684 Small molecule or natural product Ligand has a PDB structure Hs Inhibitor Inhibition 7.9 pKd
tamatinib Small molecule or natural product Ligand has a PDB structure Immunopharmacology Ligand Hs Inhibitor Inhibition 7.1 pKd
lestaurtinib Small molecule or natural product Ligand has a PDB structure Immunopharmacology Ligand Hs Inhibitor Inhibition 6.9 pKd
KW-2449 Small molecule or natural product Hs Inhibitor Inhibition 6.7 pKd
midostaurin Small molecule or natural product Approved drug Ligand has a PDB structure Immunopharmacology Ligand Hs Inhibitor Inhibition 6.4 pKd
fedratinib Small molecule or natural product Approved drug Ligand has a PDB structure Hs Inhibitor Inhibition 6.0 pKd
dovitinib Small molecule or natural product Hs Inhibitor Inhibition 5.8 pKd
SU-14813 Small molecule or natural product Hs Inhibitor Inhibition 5.7 pKd
SB203580 Small molecule or natural product Immunopharmacology Ligand Hs Inhibitor Inhibition <5.5 pKd
Displaying the top 10 most potent ligands  View all ligands in screen »
EMD Millipore KinaseProfilerTM screen/Reaction Biology Kinase HotspotSM screen Click here for help
A screen profiling 158 kinase inhibitors (Calbiochem Protein Kinase Inhibitor Library I and II, catalogue numbers 539744 and 539745) for their inhibitory activity at 1µM and 10µM against 234 human recombinant kinases using the EMD Millipore KinaseProfilerTM service.

A screen profiling the inhibitory activity of 178 commercially available kinase inhibitors at 0.5µM against a panel of 300 recombinant protein kinases using the Reaction Biology Corporation Kinase HotspotSM platform.

http://www.millipore.com/techpublications/tech1/pf3036
http://www.reactionbiology.com/webapps/main/pages/kinase.aspx

Reference: ...1
Key to terms and symbols Click column headers to sort
Target used in screen: nd/MARK4
Ligand Sp. Type Action % Activity remaining at 0.5µM % Activity remaining at 1µM % Activity remaining at 10µM
staurosporine Small molecule or natural product Ligand has a PDB structure Hs Inhibitor Inhibition 0.0
K-252a Small molecule or natural product Hs Inhibitor Inhibition 0.9
JAK3 inhibitor VI Small molecule or natural product Hs Inhibitor Inhibition 1.6
Cdk1/2 inhibitor III Small molecule or natural product Ligand has a PDB structure Hs Inhibitor Inhibition 2.3
midostaurin Small molecule or natural product Approved drug Ligand has a PDB structure Immunopharmacology Ligand Hs Inhibitor Inhibition 3.2
SB 218078 Small molecule or natural product Hs Inhibitor Inhibition 5.3
SU11652 Small molecule or natural product Ligand has a PDB structure Hs Inhibitor Inhibition 7.2
Gö 6976 Small molecule or natural product Ligand has a PDB structure Hs Inhibitor Inhibition 10.8
PKR inhibitor Small molecule or natural product Ligand has a PDB structure Hs Inhibitor Inhibition 12.8
sunitinib Small molecule or natural product Approved drug Ligand has a PDB structure Hs Inhibitor Inhibition 24.7
Displaying the top 10 most potent ligands  View all ligands in screen »

References

Show »

1. Anastassiadis T, Deacon SW, Devarajan K, Ma H, Peterson JR. (2011) Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol, 29 (11): 1039-45. [PMID:22037377]

2. Davis MI, Hunt JP, Herrgard S, Ciceri P, Wodicka LM, Pallares G, Hocker M, Treiber DK, Zarrinkar PP. (2011) Comprehensive analysis of kinase inhibitor selectivity. Nat Biotechnol, 29 (11): 1046-51. [PMID:22037378]

3. Drewry DH, Annor-Gyamfi JK, Wells CI, Pickett JE, Dederer V, Preuss F, Mathea S, Axtman AD. (2022) Identification of Pyrimidine-Based Lead Compounds for Understudied Kinases Implicated in Driving Neurodegeneration. J Med Chem, 65 (2): 1313-1328. [PMID:34333981]

4. Li F, Liu Z, Sun H, Li C, Wang W, Ye L, Yan C, Tian J, Wang H. (2020) PCC0208017, a novel small-molecule inhibitor of MARK3/MARK4, suppresses glioma progression in vitro and in vivo. Acta Pharm Sin B, 10 (2): 289-300. [PMID:32082974]

5. Shi YQ, Sun ZH, Wang ZZ, Su CY, Zhang W, Yu LY, Xu Y, Gao YL, Wang HB, Tian JW et al.. (2023) A novel role for microtubule affinity-regulating kinases in neuropathic pain. Br J Pharmacol, [Epub ahead of print]. [PMID:38112022]

6. Wodicka LM, Ciceri P, Davis MI, Hunt JP, Floyd M, Salerno S, Hua XH, Ford JM, Armstrong RC, Zarrinkar PP et al.. (2010) Activation state-dependent binding of small molecule kinase inhibitors: structural insights from biochemistry. Chem Biol, 17 (11): 1241-9. [PMID:21095574]

How to cite this page

MARK subfamily: microtubule affinity regulating kinase 4. Last modified on 12/03/2024. Accessed on 16/04/2024. IUPHAR/BPS Guide to PHARMACOLOGY, https://www.guidetoimmunopharmacology.org/GRAC/ObjectDisplayForward?objectId=2100.